| | 98753-19-6 Basic information More.. |
| Product Name: | Cefpirome sulfate | | Synonyms: | 1-[[(6r,7r)-7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-dihydro-5h-cyclopenta[b]pyridinium sulfate;CEFPIROME SULFATE;Keitin);Cefquinome base;CefpiromeSulfate3%;1-(((6R,7R)-7-((Z)-2-(2-AMinothiazol-4-yl)-2-(MethoxyiMino)acetaMido)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)Methyl)-6,7-dihydro-5H-cyclopenta[b]pyridin-1-iuM hydrogensulfate;(6r-rboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-;5h-1-pyrindinium,1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-ca | | CAS: | 98753-19-6 | | MF: | C22H24N6O9S3 | | MW: | 612.66 | | EINECS: | 685-392-7 | | Mol File: | 98753-19-6.mol |  |
Use
Cefpirome sulfate is a new injectable cephalosporin indicated for the treatment of
severe urinary and respiratory tract infections, including septicemia and nosocomial
infections. Cefpirome sulfate is reported to be the first true fourth-generation
cephalosporin due to its similar activities to third-generation antibiotics against
Gram-positive bacteria and to first-generation antibiotics against Gram-negative
bacteria. Its efficacy against P.aeruginosa is comparable to ceftazidime. The broad
spectrum of activity includes Klebsiella, methicillin-sensitive staphylococci,
penicillin-resistant pneumococci, E.coli which generates extended-spectrum
beta-lactamases and multi-resistant organisms such as Citrobacter, Enterobacter and
Serratia.
- Cefpirome sulfate
-
- US $0.00 / kg
- 2025-05-12
- CAS:98753-19-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10000KGS
- Cefpirome sulfate
-
- US $1.00 / KG
- 2025-04-23
- CAS:98753-19-6
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 10mt
- Cefpirome Sulfate
-
- US $0.00 / kg
- 2025-04-02
- CAS:98753-19-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 20tons
|
|
98753-19-6
Recommend Suppliers |
|